2 completed, 1 recruiting, 1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Cytogenetic Abnormality: new trials by email Literature Review of Cytogenetic Abnormality trials Research Report on Cytogenetic Abnormality
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies Fludarabine, Busulfan, Melphalan - Hematologic Malignancy, Acute Leukemia | Phase 2 | Recruiting | Masonic Cancer Center, University of Minnesota | 70 | 2023-05-11 | 2026-04-06 |
| Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML VAH regimen, VEN+HMA regimen - Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Completed | Nanfang Hospital, Southern Medical University | 231 | 2018-12-03 | 2022-07-13 | |
| Genomic Instability in Vascular Surgeons Cytogenetic analysis - Cytogenetic Abnormality, Radiation Exposure | Completed | Hospital Clínico Universitario de Valladolid | 28 | 2018-11-09 | 2020-04-27 | |
| Risk-stratified Therapy Based on Molecular Cytogenetic Aberration and Treatment Response in AML Justified risk stratification based on MRD after three course chemo therapy - Risk-directed Therapy, Cytogenetic Abnormality | Unknown | Nanfang Hospital, Southern Medical University | 1000 | 2018-08-10 | 2019-11-04 |
Chromosome Aberrations (4) · Leukemia, Myeloid, Acute (2) · Anemia, Refractory, with Excess of Blasts (1) · Chromosome 7, monosomy (1) · Congenital Abnormalities (1) · Hematologic Neoplasms (1) · Influenza, Human (1) · Leukemia, Myelomonocytic, Juvenile (1) · Neoplasm, Residual (1) · Neurofibromatosis 1 (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1) · beta-Thalassemia (1)
Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Leukemia (2) · Leukemia, Myeloid (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Anemia, Refractory (1) · Bone Marrow Diseases (1) · Disease Attributes (1)
Busulfan (1) · Cyclophosphamide (1) · Cytogenetic Analysis (1) · Levetiracetam (1) · Melphalan (1) · Rituximab (1) · fludarabine (1) · thymoglobulin (1)
Nanfang Hospital, Southern Medical University (2) · Hospital Clínico Universitario de Valladolid (1) · Masonic Cancer Center, University of Minnesota (1)
China (2) · Spain (1) · United States (1)
Liu Qifa, MD (1) · Margaret MacMillan (1) · Qifa Liu (1)
PMID 17157333, PMID 18039723, PMID 18082557, PMID 19560006, PMID 20020300, PMID 20093507, PMID 20723835, PMID 21147004, PMID 23871303, PMID 24156970, PMID 24440812, PMID 24966273, PMID 25476871, PMID 25818982, PMID 26902938, PMID 27272147, PMID 28127123, PMID 29577646, PMID 29705904, PMID 30028182, PMID 30322344, PMID 31232047, PMID 31267420, PMID 40437173, PMID 42410464